Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: A study
Indian Journal of Dermatology, 2013 Background: Warts are sometimes resistant or they tend to recur after every possible destructive therapy. Immunotherapy with skin-test antigens has been used as a viable therapeutic option in such recalcitrant cases.
Imran Majid, Saher Imran
doaj +4 more sources
Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology [PDF]
Critical Reviews in Oncogenesis, 2016 The last few years have yielded exciting developments in immunotherapy for cancer. The promise of cancer immunotherapy has been well known for many years, but had generally produced limited or inconsistent benefit to patients. Intralesional therapies, which are in fact one of the oldest forms of immunotherapy, are also demonstrating benefits in the ...
Mark Faries
exaly +5 more sources
Intralesional immunotherapy for the treatment of anogenital warts in pediatric population
Journal of Dermatological Treatment, 2020 The prevalence of anogenital warts is increasing in adults as well as in pediatric population. The treatment of anogenital warts is challenging, particularly in children as most conventional modalities are painful and associated with high recurrence rates.To evaluate the efficacy and safety of intralesional immunotherapy for the treatment of anogenital
Ahmad, Nofal, Rania, Alakad
openaire +3 more sources
Intralesional antigen immunotherapy of Warts: Review Article [PDF]
Zagazig University Medical JournalCommon epidermal growths called warts are brought on by the human papillomavirus and can be extremely uncomfortable and embarrassing. Topical medications, cryotherapy, laser vaporization, and surgical excision are among the available treatment options ...
Waleed Al-Balat +2 more
doaj +2 more sources
Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma [PDF]
Cancers, 2020 The incidence of cutaneous melanoma, a highly malignant skin cancer, is increasing yearly. While surgical removal of the tumor is the mainstay of treatment for patients with locally confined disease, those with metastases face uncertainty when it comes to their treatment.
Dejan Vidovic, Carman Giacomantonio
openaire +3 more sources
Intralesional immunotherapy for the treatment of warts: a mini review [PDF]
Zagazig University Medical Journal, 2021 Warts are common dermatological disease. They occur due to infection by the human papilloma virus. They can occur at any site and any age. Sometimes they persist for many years and their treatment become difficult and depressing for dermatologists and ...
enas abdelwahab +2 more
doaj +2 more sources
Academic Medicine & SurgeryMolluscum contagiosum is a poxvirus-induced skin infection that typically resolves spontaneously but may persist and become refractory in adults. We report a 38-year-old immunocompetent male with over 40 lesions on the trunk, forearms, and pubic region ...
Randa Haji +6 more
doaj +2 more sources
Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts? [PDF]
Oman Medical Journal, 2022 Mahmood Dhahir Al-Mendalawi
doaj +2 more sources
Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives. [PDF]
Int J Mol SciCutaneous warts caused by human papillomavirus (HPV) are among the most common dermatological conditions, affecting the quality of life of numerous people.
Kucharczyk E +4 more
europepmc +2 more sources
Efficacy of intralesional Candida antigen immunotherapy in treatment of recalcitrant warts. [PDF]
Zagazig University Medical Journal, 2020 Background Despite existence of different therapeutic modalities, treatment of warts especially recalcitrant one remains a continuing challenge as there is no treatment modality exhibited high efficiency and low recurrence rate.
Ayman Marei +3 more
doaj +1 more source